pillbase.ru

Synjardy XR

Active substance: EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

TABLET, EXTENDED RELEASE · EMPAGLIFLOZIN 5 mg/1, METFORMIN HYDROCHLORIDE 1000 mg/1

United StatesActive

Marketing holder: Boehringer Ingelheim Pharmaceuticals, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing empagliflozin in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
EU 3
  • Glyxambi
    empagliflozin, linagliptin
    EMEA/H/C/003833
    Boehringer Ingelheim International GmbH
  • Jardiance
    empagliflozin
    EMEA/H/C/002677
    Boehringer Ingelheim International GmbH
  • Synjardy
    empagliflozin, metformin
    EMEA/H/C/003770
    Boehringer Ingelheim
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-272c-758b-875f-ac5c4b08e323,01a1208d-2aa1-733b-9dfa-5e06933877ab,01a1208d-c645-77f4-8792-c3e899ac7740,01a1208e-7781-7598-b3db-a49916cb774e,01a12090-fcd7-736d-a242-758dc155fa2e;count=11 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0597-0290
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0597-0290 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0597-0290 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0597-0290 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 0597-0290 · Verified 2026-10-09 · open in source